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Abstract
Purpose Exercise-induced changes in intestinal permeability are exacerbated in the heat. The aim of this study was to 
determine the effect of 14 days of bovine colostrum (Col) supplementation on intestinal cell damage (plasma intestinal fatty 
acid-binding protein, I-FABP) and bacterial translocation (plasma bacterial DNA) following exercise in the heat.
Methods In a double-blind, placebo-controlled, crossover design, 12 males completed two experimental arms (14 days of 
20 g/day supplementation with Col or placebo, Plac) consisting of 60 min treadmill running at 70% maximal aerobic capac-
ity (30 °C, 60% relative humidity). Blood samples were collected pre-exercise (Pre-Ex), post-exercise (Post-Ex) and 1 h 
post-exercise (1 h Post-Ex) to determine plasma I-FABP concentration, and bacterial DNA (for an abundant gut species, 
Bacteroides).
Results Two-way repeated measures ANOVA revealed an arm × time interaction for I-FABP (P = 0.005, with greater Post-
Ex increase in Plac than Col, P = 0.01: Plac 407 ± 194% of Pre-Ex vs Col, 311 ± 134%) and 1 h Post-Ex (P = 0.036: Plac 
265 ± 80% of Pre-Ex vs Col, 229 ± 56%). There was no interaction (P = 0.904) but there was a main effect of arm (P = 0.046) 
for plasma Bacteroides/total bacterial DNA, with lower overall levels evident in Col.
Conclusion This is the first investigation to demonstrate that Col can be effective at reducing intestinal injury following 
exercise in the heat, but exercise responses (temporal pattern) of bacterial DNA were not influenced by Col (although overall 
levels may be lower).
Keywords Intestinal fatty acid-binding protein · Cellular injury · Strenuous exercise · Bacterial translocation · Intestinal 
permeability · Core temperature · Environment
Abbreviations
ANOVA  Analysis of variance
Col  Bovine colostrum
DNA  Deoxyribonucleic acid
Hb  Haemoglobin
HR  Heart rate
HSP  Heat shock protein
I-FABP  Intestinal fatty acid-binding protein
I-R  Ischaemia–reperfusion
LAL  Limulus amoebocyte lysate assay
LPS  Lipopolysaccharide
NAT  Nucleic acid testing
Plac  Placebo
PCR  Polymerase chain reaction
RPE  Rating of perceived exertion
L/R  Urinary excretion ratio between lactulose and 
rhamnose
TJ  Tight junction
Introduction
Increases in core temperature, and heat stress along with 
intestinal hypoperfusion, and ischaemia–reperfusion (I–R), 
contribute to intestinal injury and changes in permeability 
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during exercise [1–7]. These physiological responses are 
likely exacerbated when exercising in hot and humid envi-
ronments. Moreover, exercise in the heat is both common 
and necessary in many sport (for athletes) or work contexts 
(e.g. military, firefighters). However, under extreme cir-
cumstances exhaustive exercise in such environments can 
result in severe endotoxaemia (the translocation of bacterial 
lipopolysaccharide (LPS) into the central circulation) [8, 9], 
through intestinal injury and changes in permeability, which 
is thought to be associated with acute inflammation, sepsis, 
shock and organ failure that in rare cases may be fatal.
Nutritional interventions to maintain the integrity of the 
intestinal barrier and, therefore, avoiding these complications 
during and following exercise in the heat are somewhat lim-
ited. However, bovine colostrum (Col) has shown to be both 
effective in blunting the heat-induced increase in permeabil-
ity in vitro and in vivo in animals and humans [1, 2, 10, 11]. 
Previously Col has blunted both the exercise-induced increase 
in intestinal permeability and circulating intestinal fatty acid-
binding protein (I-FABP) (a marker of intestinal cellular injury) 
in the exercise stress model in humans where an increase of 
~ 1.5 °C in core temperature was observed [1, 2, 11].
It is important to note, however, that this increase (fol-
lowing 20 min of running at 80% V̇O2peak ) may be relatively 
mild considering that strenuous athletic events in the heat 
can evoke much higher elevations in core temperatures [12, 
13]. The implications of changes to the intestinal barrier 
during exercise and heat is an issue of increased significance 
as there is a global increase in ambient temperatures during 
athletic competition [14].
We have previously shown that changes in plasma I-FABP 
immediately following treadmill running occur concurrently 
(and correlate) with changes in intestinal permeability as 
measured by the 5-h urinary excretion ratio between lactu-
lose and rhamnose (L/R) [2], and also that both are blunted 
by Col supplementation. However, a recent study [15] has 
indicated that when core temperature is elevated above 39 °C 
during exercise then Col may not be effective in blunting 
the increase in plasma I-FABP. Although, in this study [15] 
there were variable running times between the two condi-
tions [placebo (Plac) and Col], imposing different stresses 
that may have compromised the validity of these results.
Some previous investigations have quantified changes 
in circulating LPS following exercise [16, 17] to indicate 
changes in intestinal permeability. However, there are 
issues pertaining to the collection and analysis of blood 
samples [through the limulus amoebocyte lysate assay 
(LAL)], in addition to the detection of LPS, suggesting that 
this marker may not be ideal [18, 19]. Some clinical studies 
have measured intestinal-derived circulating bacterial DNA 
via 16S rDNA PCR assays to indicate changes in intestinal 
permeability [19–22], which has been suggested to be more 
specific to targeted bacterial strains and can overcome some 
of the sensitivity and specificity issues that exist for the 
LPS LAL assays. However, circulating bacterial DNA (as 
a marker of bacterial translocation) has not previously been 
assessed within an exercise and heat stress model.
Therefore, the primary aim of this study is to determine 
whether 14 days of oral Col supplementation can blunt the 
heat- and exercise-induced increase in intestinal injury meas-
ured by plasma I-FABP. The secondary aim was to deter-
mine the effects on circulating bacterial DNA, as a marker 
of bacterial translocation. It is hypothesised that exercise and 
heat would present a larger challenge to intestinal integrity 
(greater increase in plasma I-FABP) and intestinal perme-
ability than we observed in exercise alone in our previous 
work [2], resulting in a large increase in this injury marker 
and circulating bacterial DNA. However, it is hypothesised 
that Col supplementation would blunt these increases.
Methods
Ethical approval
The study was conducted in accordance with the Declaration 
of Helsinki and approved by the Aberystwyth University 
Research Ethics Committee. All participants were informed 
both verbally and in writing of the nature and risks of the 
experimental procedures after which written consent was 
obtained at least 7 days prior to the preliminary visit.
Sample size
Based on our previous observed [2] post-exercise change 
(compared to pre-exercise) in plasma I-FABP with 18 
participants (no dropouts) (297 ± 285 pg/mL for Plac and 
6 ± 283 pg/mL for Col), we calculated (G*Power version 
3.1.9.1, Kiel, Germany) that n = 12 was required to detect a 
significant difference between Plac and Col arms with 95% 
power and alpha set at 0.05.
Participants
Twelve healthy male participants who were all regular exer-
cisers participated in this study (mean ± SD: age 26 ± 6 years; 
body mass 79.5 ± 9.4 kg; height 180 ± 7 cm; body mass 
index 24 ± 2 kg m−2; V̇O2peak 55.8 ± 4.8 mL kg−1 min−1; 
peak speed in ramp test 18.2 ± 0.8 km h−1; running speed 
at 70% V̇O2peak 11.0 ± 0.6 km h−1). All trials took place 
between October 2013 and March 2014 in the United King-
dom. The range for average air temperature measured at a 
local climate station (25 miles from our laboratory) for these 
months has been reported as 3.8–14.8 °C (http://www.metof 
fice.gov.uk).
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Inclusion/exclusion criteria
Inclusion criteria were: age 18–45 years, free of illness 
symptoms for 4 weeks prior to the study, and no non-steroi-
dal anti-inflammatory drug consumption or other use (e.g. 
via over the counter creams) for 4 weeks prior to the study. 
Individuals were unable to participate if they were currently 
a smoker, had any history of gastrointestinal disorders or sur-
gery, or were allergic or intolerant to dairy products. Partici-
pants were also excluded if they were not able to complete 
an exercise test that required maximum effort or had recent 
history (< 6 months) of supplement use or a history of previ-
ous heat injury/heat stroke. All participants were permanent 
residents in the United Kingdom for at least 8 weeks before 
beginning the study.
Study design and nutritional intervention
In this double-blind, placebo-controlled, randomised, cross-
over study, participants were required to undertake exercise 
under two conditions (study arms): Plac supplementa-
tion or Col with a minimum ‘washout period’ of 2 weeks 
between arms (Fig. 1). We have previously shown that a 
‘washout’ period of 2 weeks is sufficient for Col and there 
are no carry-over effects for plasma I-FABP [2], or other 
markers of intestinal permeability [2, 11, 23]. For each arm, 
participants performed one preliminary visit (determination 
of running speed at 70% V̇O2peak ), one familiarisation and 
one main trial over an approximate 2-week period. Partici-
pants supplemented with 20 g day−1 (10 g prior to morning 
and evening meal) of either Plac or Col for 14 days, which 
was administered in a randomised crossover fashion using 
an online randomisation tool (http://www.rando mizat ion.
com). Four participants’ first-test substance was Plac whilst 
eight ingested Col as the first-test substance. Two days into 
the supplementation period participants performed a trial 
to determine running speed at 70% V̇O2peak . Seven days 
into the supplementation period participants performed the 
familiarisation trial. Seven days later participants performed 
the main trial. After at least 2 weeks of washout, these pro-
cedures were repeated with participants supplementing with 
the opposite test substance (Plac or Col). Supplements were 
supplied in sealed tubes labelled as ‘A’ and ‘B’ by an inde-
pendent investigator who was not involved in the data col-
lection or analysis. Investigators were unblinded following 
the completion of data collection and analysis. Participants 
completed a 24-h food diary on the day before the first exer-
cise visit and repeated this diet for the subsequent exercise 
visit in the opposing arm. Participants were instructed to 
avoid alcohol consumption and strenuous activity or exercise 
for 2 days before each preliminary and main exercise visit.
Bovine colostrum
The Col was supplied by Neovite UK as used in previous 
studies from our laboratory [2, 11]. The approximate energy 
content was 311.5 kJ (74.4 kcal) per 20 g [i.e. 80% protein, 
9% carbohydrate (lactose), 1.8% fat]. The placebo was an 
isoenergetic and isomacronutrient milk protein concentrate 
and was indistinguishable in terms of appearance and taste 
from the Col powder.
Preliminary visits
Participants reported to the laboratory, and body mass and 
stature were recorded. Body mass was recorded using labo-
ratory scales (Seca 899, Seca GmbH & Co, Hamburg, Ger-
many) with the participants unshod and wearing the same 
clothing as during the experimental trials (typically light-
weight shorts and t-shirt). Following this, participants com-
pleted a graded exercise treadmill test (Woodway Ergo-Line 
Treadmill PPS55i Med, Woodway GmbH, Weil am Rhein, 
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Fig. 1  Schematic of study design. Each participant took part in a 
double-blind, placebo-controlled, randomised, crossover study. Par-
ticipants received oral supplementation with 20 g day−1 of either Plac 
or Col for 14 days with a 14-day washout period between study arms. 
After the 14-day washout these procedures were repeated with par-
ticipants supplementing with the opposite-test substance (Plac or Col)
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Germany) to voluntary exhaustion with the grade set at 1% 
[24], as previously described [25].
Familiarisation trial
A familiarisation trial took place 7 days before the main trial 
to ensure that all participants were accustomed to the test-
ing procedure and ensure that the correct exercise intensity 
had been identified from the preliminary trial. Participants 
performed 60 min of treadmill running at 70% V̇O2peak . Core 
body temperature, heart rate (HR), rating of perceived exer-
tion (RPE) [26], and thermal sensation were recorded using 
a 21-point scale ranging from − 10 (cold impossible to bear) 
to + 10 (heat impossible to bear) (used previously in our 
laboratory during nutritional studies of exercise in the heat 
by Tumility et al. [27, 28]) every 10 min during the trial. 
Fluid (ordinary tap water) was provided to participants at a 
rate of 2.5 mL kg body mass−1 every 20 min during exercise. 
The purpose of this trial was to habituate the participants to 
the physiological measurements (mentioned above) and to 
exercising in the heat.
Main trial
Following an overnight fast, participants consumed 500 mL 
of ordinary tap water 1 h before arriving at the laboratory 
at 07:00, and confirmed verbally that they had adhered to 
the supplement intake instructions and other study require-
ments. Participants were then asked to remain seated for 
10 min before a blood sample was drawn (Pre-Ex) (less than 
30 s of stasis) from the antecubital vein using a 21-gauge 
precision needle (Becton–Dickinson, Oxford, UK) and col-
lected into vacutainer tubes (6 mL into  K2EDTA-treated 
tube and 6 mL into a heparin-treated tube, BD Vacutainer 
Systems, Plymouth, UK). Following this participants pro-
vided a urine sample (Pre-Ex), and the volume was recorded 
before an aliquot was removed and immediately frozen at 
− 80 °C for later measurement of osmolality using freezing 
point depression (CV for urine osmolality 4%) (Osmomat 
030, Gonotec, Berlin, Germany). A rectal thermistor (Grant 
Instruments, Cambridge, England) was self-positioned by 
each participant 10 cm beyond the anal sphincter to enable 
core temperature measurement and a short-range heart rate 
telemetry band was fitted (Polar S610i, Polar Electro Oy, 
Tampere, Finland). Participants then entered the climatic 
chamber (Design Environmental, Gwent, Wales, UK) 
which was maintained at 30.0 ± 0.1 °C, and 60 ± 0% rela-
tive humidity (monitored every 20 min) and placed their feet 
either side of the treadmill belt until the relevant speed was 
attained. They were then instructed to begin running at a 
constant speed equivalent to 70% V̇O2peak on a motorised 
treadmill with a 1% grade [24] for 60 min or until core 
temperature reached 40 °C (whichever came first). Fluid 
(ordinary tap water) was provided to participants at a rate of 
2.5 mL kg body mass−1 every 20 min during exercise. HR, 
RPE, and thermal sensation were recorded using the scales 
previously described every 10 min during the trial. Core 
body temperature was also recorded every 10 min during 
the trial and then again 5 min following the cessation of 
exercise (the change between pre-exercise and peak, which 
was always 5 min post, was calculated). The mean of the 
physiological responses were calculated to ensure a similar 
physical stress was imposed between arms. Following run-
ning, participants were instructed to support their weight 
with their hands on the hand rails and place their feet either 
side of the treadmill belt. Participants were then immediately 
removed from the climatic chamber and seated outside and 
a further venous blood sample (Post-Ex) was obtained. A 
maximum of 3 min elapsed between end of exercise and this 
blood sample being drawn. Participants then remained in the 
laboratory until 1 h post-exercise when a further (1 h Post-
Ex) venous blood sample and urine sample were obtained.
Blood analysis
Haemoglobin (Hb) was determined on EDTA-treated blood 
samples using an automated haematology analyser (ABX 
Pentra 60C+, Horiba Medical, Montpellier, France). Blood 
lactate and blood glucose (from the heparin-treated tube) 
were determined using an automated analyser (YSI 2300 
Stat Plus, Yellow Springs, OH, USA), and haematocrit was 
determined by standard microcentrifugation (Micro Haema-
tocrit Mk5 Centrifuge, Hawkesley, Lancing, UK). Haemato-
crit and Hb concentration were used to estimate post-exer-
cise changes in blood and plasma volume (compared to the 
Pre-Ex sample) using the equations of Dill and Costill [29]. 
The blood sample collected in the  K2EDTA-treated tube was 
centrifuged at 1500×g for 10 min at 4 °C. The plasma from 
the  K2EDTA-treated tube was pipetted into polypropylene 
microcentrifuge tubes (Eppendorf, Hamburg, Germany) 
before being stored at − 80 °C for later analysis (plasma 
I-FABP).
Plasma I‑FABP analyses
Plasma I-FABP was determined in duplicates via an ELISA 
kit (Hycult, Biotechnology, Uden, The Netherlands) accord-
ing to the manufacturer’s instructions. Sterile procedures 
were observed throughout the assay. Inter-assay CV was 
6.9%. As a result of large inter-participant variability in 
plasma I-FABP, we [2], and other groups [30–32], have 
previously reported plasma I-FABP as both an absolute 
change (in pg/mL) and a percentage change, compared to 
pre-exercise. To be consistent with these previous reports 
we have once again presented changes in this marker as both 
percentage and absolute values.
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Plasma bacterial DNA
Bacterial DNA was detected using a quantitative real-time 
polymerase chain reaction assay (qPCR) on a LightCycler 
96 instrument (Roche, Basel, Switzerland). DNA was iso-
lated from plasma using a QIAamp DNA blood mini kit 
(QIAGEN GmbH, Hilden, Germany) in accordance with the 
manufacturer’s instructions. Total bacterial DNA was quan-
tified by the methods of Zhu et al. [33] using a Universal 
probe library probe (Roche, Basel, Switzerland) and primers 
specific to a 16S region (Eurogentec, Liège, Belgium). Bac-
teroides species (an abundant species found in the gut) DNA 
was quantified using a commercially available double-dye 
probe and primer kit for all Bacteroides species, targeted to 
a 16S specific region common to Bacteroides species only 
(Path-Bacteroides_spp, Genesig, Primerdesign Ltd, Chan-
dler’s Ford, UK). Results are presented as Bacteroides/total 
bacterial DNA ratio.
Statistical analysis
All statistical analyses of data were performed using the 
Statistical Package for Social Sciences (SPSS for Win-
dows, version 21.0, IBM, New York, USA). All data are 
presented as mean values ± standard deviation (SD) unless 
otherwise stated. Data were checked for normal distribution 
by observing the P value from the Shapiro–Wilk test. Data 
not normally distributed (absolute plasma I-FABP, Bacte-
roides/total bacterial DNA ratio) were normalised by natu-
ral log (base-e) transformation prior to analysis. A two-way 
repeated measures ANOVA (arm × time) was performed to 
compare temporal responses between each arm (Plac and 
Col) for plasma volume change, HR, RPE, thermal sensa-
tion, plasma glucose, plasma lactate, urine volume, urine 
osmolality, core temperature, total leukocytes, neutrophils, 
total lymphocytes, neutrophils to total lymphocytes ratio 
(NEU/LYM), monocytes, absolute plasma I-FABP, percent 
change plasma I-FABP and Bacteroides/total bacterial DNA 
ratio. When a main interaction effect was evident, a post hoc 
paired samples t test with Holm–Bonferroni correction was 
performed on the change (for time) between arms (Plac and 
Col). Effect size (ES) was calculated using Cohen’s d for the 
Post-Ex and 1 h Post-Ex difference from Pre-Ex between 
arms (Plac and Col) for plasma I-FABP (absolute and per-
cent change), when a main interaction was evident. To deter-
mine any associations, Post-Ex values for absolute plasma 
I-FABP and Bacteroides/total bacterial DNA ratio were 
assessed using Pearson’s correlation. It is not possible to 
pool the data for a single analysis as the repeated measures 
design (each participant undertook both Plac and Col arms) 
means this would violate the assumption that observations 
are independent (required for correlation analysis). As such, 
each main visit was analysed separately for correlations. We 
chose to analyse the participants’ visit 1 and visit 2 sepa-
rately (consistent with previous analysis with similar data 
by our group [2]) to ensure the necessary independence of 
observations in each analysis but also ensuring that each 
analysis contained a mixture of Plac and Col conditions, and 
hence gave a good representation of the true spread of data 
for each measure within the study. Statistical significance 
was accepted at P < 0.05 level.
Results
Physiological variables and hydration status
One participant completed 56 min of the 60 min protocol 
in both trials due to core temperature reaching termination 
criteria (40 °C), but as this occurred at the same point in 
both trials (and because it was so close to the full 60 min 
duration) they were still included in the final data analysis. 
The response of physiological variables (HR, RPE, thermal 
sensation, plasma glucose, plasma lactate, urine volume, 
urine osmolality) to exercise was similar between arms (Col 
and Plac) (Table 1). A similar pattern of plasma volume 
change was observed from Pre-Ex between arms: Plac; Post-
Ex [− 12.6 ± 2.7]; 1 h Post-Ex [− 6.2 ± 2.8] and Col; Post-Ex 
[− 13.7 ± 1.7]; 1 h Post-Ex [− 6.6 ± 2.5], with no significant 
difference between arms (P = 0.552), as a result no param-
eters were corrected for plasma volume changes.
Immune cell counts
The response of immune cell counts was similar between 
arms (Table 2).
Core temperature
The increase for core temperature was similar in Plac and 
Col arms (ANOVA effect of arm P = 0.997; effect of time 
P < 0.001; and arm × time interaction P = 0.473). The mean 
increase for core temperature was 2.6 ± 0.5 and 2.4 ± 0.6 °C 
for Plac and Col arms, respectively (Plac 36.8 ± 0.4 to 
39.3 ± 0.6 °C; Col 36.8 ± 0.4 to 39.3 ± 0.7 °C).
Plasma I‑FABP
For absolute plasma I-FABP concentration, there was no 
main effect of arm (P = 0.605). There was a significant main 
effect of time (P < 0.0001), and arm × time interaction effect 
(P = 0.005). The Pre-Ex concentrations were similar between 
Plac and Col arms (P = 0.085). Post hoc analysis showed that 
absolute plasma I-FABP concentration [median and (inter-
quartile range)] significantly increased from Pre-Ex [661 
(571) pg/mL] to Post-Ex [1924 (1394) pg/mL] (P = 0.01, ES 
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0.36), and remained elevated at 1 h Post-Ex [993 (598) pg/
mL] (P = 0.036, ES 0.39) in the Plac arm to a greater extent 
compared to Col, Pre-Ex [727 (682)], Post-Ex [1781 (1603)], 
1 h Post-Ex [993 (598)]. When analysed for percent change, 
there was a main effect of arm (P = 0.011), time (P = 0.03), 
and an arm × time interaction effect (P = 0.017). Post hoc 
analysis showed that percent change in plasma I-FABP con-
centration significantly increased at Post-Ex (407 ± 194%, 
P = 0.015, ES 0.6) and 1 h Post-Ex (265 ± 80%, P = 0.019, 
ES 0.55) in the Plac arm to a greater extent compared to 
Col, Post-Ex (311 ± 134%), 1 h Post-Ex (229 ± 56%) (Fig. 2).
Bacteroides/total 16S rDNA
For plasma Bacteroides/total 16S rDNA there was a main 
effect of arm (P = 0.046), but no effect of time (P = 0.078), or 
arm × time interaction (P = 0.904). Pre-Ex values were simi-
lar between Plac and Col arms (P = 0.540). Bacteroides/total 
16S rDNA concentrations [median and (interquartile range)] 
were 2.76 [3.54] × 10−4 at Pre-Ex, 4.55 [8.96] × 10−4 at 
Post-Ex, and 3.91 [6.24] × 10−4 at 1 h Post-Ex, and 3.39 
[4.02] × 10−4 at Pre-Ex, 2.87 [8.94] × 10−4 at Post-Ex, and 
2.72 [3.81) × 10−4 at 1 h Post-Ex, for the Plac and Col arms, 
respectively (Fig. 3).
Association between absolute plasma I‑FABP 
and Bacteroides/total 16S rDNA
The Pearson’s correlation analysis showed that Post-Ex 
absolute plasma I-FABP concentration significantly cor-
related with the Post-Ex Bacteroides/total 16S rDNA for 
Visit 1 (P = 0.038, Rs = 0.603) but not Visit 2 (P = 0.060, 
Rs = 0.557), although plots do suggest similar overall pat-
terns (see Fig. 4).
Table 1  Physiological, hydration status, and perceptual responses to exercise trials
Post hoc comparisons for main effect of time (overall owing to no interaction effect): *significantly increased (P < 0.01) compared to 1st meas-
ured time point (Pre-Ex or 10 min)
Pre-Ex 10 min 20 min 30 min 40 min 50 min 60 min Post-Ex 1 h ANOVA P val-
ues (arm; time; 
arm × time)
HR (bpm) * * * * * *
 Plac 70 ± 12 152 ± 16 163 ± 16 169 ± 16 176 ± 16 180 ± 15 181 ± 14 0.425; <0.0001; 0.095
 Col 67 ± 11 155 ± 15 161 ± 14 169 ± 14 177 ± 13 180 ± 12 184 ± 10
RPE * * * * *
 Plac 10 ± 2 11 ± 1 12 ± 1 13 ± 1 15 ± 2 15 ± 2 0.210; < 0.0001; 0.806
 Col 10 ± 2 11 ± 2 13 ± 1 14 ± 2 15 ± 2 16 ± 2
Thermal sensa-
tion
* * * * *
 Plac 2 ± 1 3 ± 1 4 ± 1 5 ± 1 6 ± 1 6 ± 2 0.370; < 0.0001; 0.416
 Col 2 ± 1 3 ± 1 4 ± 1 5 ± 1 6 ± 1 6 ± 1
Plasma glucose 
 (mmol−1)
*
 Plac 5.06 ± 0.40 5.95 ± 0.59 4.97 ± 0.38 0.663; < 0.0001; 0.957
 Col 5.08 ± 0.48 5.92 ± 0.60 4.95 ± 0.32
Plasma lactate 
 (mmol−1)
*
 Plac 1.14 ± 0.27 3.28 ± 1.22 1.22 ± 0.27 0.619; < 0.0001; 0.206
 Col 1.08 ± 0.24 3.35 ± 1.42 1.05 ± 0.12
Urine volume 
(mL)
*
 Plac 157 ± 119 70 ± 57 0.700; 0.009; 0.304
 Col 144 ± 112 82 ± 51
Urine osmolality 
(mOsm kg−1)
 Plac 512 ± 276 592 ± 270 0.660; 0.214; 0.588
 Col 537 ± 320 635 ± 281
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Discussion
The main findings of this study are that (1) plasma I-FABP 
increased when running at 70% V̇O2peak in the heat for 
60 min, (2) 14 days of oral Col supplementation was able to 
blunt the increase in plasma I-FABP, but did not influence 
the exercise response of plasma Bacteroides/total 16S rDNA 
(although there was a main effect of arm). This is the first 
study to demonstrate the efficacy of Col in vivo on intesti-
nal injury in exercising humans within a heat and exercise 
stress model and expands on our previous work showing the 
benefit of Col on the intestines following exercise [1, 2, 11].
The increase in plasma I-FABP would suggest that intes-
tinal barrier integrity in the current study was compromised 
as changes in plasma I-FABP have previously been shown 
to be associated with increases in permeability [2]. Further-
more, these increases in plasma I-FABP following exercise 
were to a greater extent than observed in our previous study 
during thermoneutral conditions [2], and may be associated 
with changes in circulating Bacteroides/total 16S rDNA. The 
Fig. 2  Plasma I-FABP concentration (% of Pre-Ex). +Increase above 
Pre-Ex significantly greater compared to Col for Post-Ex (P = 0.015), 
and 1 h Post-Ex (P = 0.019)
Fig. 3  Bacteroides/total 16S rDNA concentration (median and inter-
quartile range). Main effect of arm (P = 0.046), but no effect of time 
(P = 0.078), or arm x time interaction effect (P = 0.904)
Table 2  Immune cell count 
responses to exercise trials
Post hoc comparisons for main effect of time (overall owing to no interaction effect): *significantly differ-
ent (P < 0.05) compared to Pre-Ex
Pre-Ex Post-Ex Post-Ex 1 h P values (arm; time; arm x time)
Total leukocytes 
(cells × 109 L−1)
* *
 Plac 5.60 ± 1.12 8.51 ± 2.00 8.47 ± 3.37 0.664; 0.003; 0.758
 Col 5.59 ± 1.10 8.36 ± 2.07 8.16 ± 3.19
Neutrophils (cells × 109 
 L− 1)
* *
 Plac 2.76 ± 0.78 4.64 ± 1.84 5.95 ± 3.10 0.470; 0.002; 0.950
 Col 2.62 ± 0.64 4.46 ± 1.83 5.69 ± 2.98
Total lymphocytes 
(cells × 109 L−1)
* *
 Plac 2.09 ± 0.43 3.06 ± 0.73 1.69 ± 0.41 0.596; <0.001; 0.305
 Col 2.21 ± 0.59 3.10 ± 0.78 1.70 ± 0.49
Neutrophils/lympho-
cytes
*
 Plac 1.35 ± 0.38 1.62 ± 0.88 3.67 ± 1.95 0.423; <0.001; 0.990
 Col 1.24 ± 0.40 1.53 ± 0.74 3.58 ± 1.93
Monocytes 
(cells × 109 L−1)
 Plac 0.52 ± 0.13 0.58 ± 0.16 0.58 ± 0.22 0.603; 0.526; 0.440
 Col 0.53 ± 0.13 0.56 ± 0.13 0.54 ± 0.13
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407 ± 194% increase in plasma I-FABP was over double the 
increase we have observed previously [2], where we reported 
a concurrent increase in intestinal permeability as measured 
by urinary L/R (5 h). Previous investigations reporting either 
significant increases in core temperature or an end core tem-
perature > 39 °C (or both as seen in the present study) with 
treadmill running observed significant changes in permeabil-
ity as measured by urinary L/R (5 h) [2, 3, 11, 34]. A recent 
study has suggested that when heat stress induces increase in 
core temperature to greater than 39 °C then Col may not be 
efficacious [15]. However this study [15] had significant limi-
tations: they only reported a 162% increase in plasma I-FABP 
despite exercising at higher ambient temperature than the 
current study (40 vs 30 °C), which was also reflected in a 
marginal greater rise in core temperature. Furthermore, the 
increase (162%) in I-FABP previously reported [15] is one 
of the lowest reported in the literature, lower than reported 
increases following high intensity interval training (172%) 
[32], following exercise in the heat (168%) [35], and follow-
ing cycling in a controlled thermoneutral condition (172%) 
[31]. This relatively low post-exercise increase in plasma 
I-FABP may explain their lack of reported effect [15] of Col 
supplementation. Moreover, McKenna et al. [15] reported 
high pre-exercise levels of plasma I-FABP which may also 
offer an explanation, and finally but perhaps most signifi-
cantly, there were variable running times between the two 
conditions, imposing different stresses between conditions 
(placebo and Col), which likely confound their results.
Running in the heat causes a greater redistribution of 
blood flow towards the cutaneous region to dissipate heat 
resulting in greater hypoperfusion, and ischaemia in the 
intestines than exercising in temperate conditions [36]. The 
increase in plasma I-FABP during exercise appears to be as 
a result of increases in core temperature, hypoperfusion and 
I-R [2, 5, 31]. Both comparable physiological temperatures 
(and lower) as reported in the present study, and hypoperfu-
sion and subsequent ischaemia result in tight junction (TJ) 
breakdown [37, 38]. Col has been previously shown to blunt 
the in vivo increase in intestinal permeability in animals 
heated to a core temperature of 41.5 °C [10]. The mechanism 
for the efficacy of Col is through an up-regulation of TJ pro-
teins (such as Claudin-1, Claudin-2 and zonula occluden-1 
protein), and its ability to induce favourable changes in cas-
pase-3, caspase-9, Baxα and Bcl-2 as has been demonstrated 
in vitro in human cell lines [1, 11, 39]. Therefore, Col is able 
to upregulate TJ proteins, maintaining cell to cell contact 
(and thus cellular integrity under stress) preventing cellular 
damage, as indicated by a blunting of plasma I-FABP in the 
Col arm. Moreover, direct protective cellular effects (e.g. 
up-regulation of heat shock protein [HSP]) prompted by Col, 
which has previously been demonstrated [1, 11], may also 
blunt the increase in plasma I-FABP.
Recent studies have shown that significant rises in core 
temperature [measured at the rectum and oesophagus 
(approx. 1.5–2 °C)] during exercise in the heat result in sig-
nificant elevations in plasma I-FABP [2, 15, 40]. The larger 
increase in core temperature (measured at the rectum) in 
the present study (~ 2.5 °C) in comparison with our previ-
ous work (1.5 °C increase) [2], was also reflected by greater 
increases in plasma I-FABP. Not only does this highlight 
the stress that both exercise and heat place on the intes-
tine (in accordance with changes in circulating I-FABP) but 
furthermore shows that this dose and timing (20 g day−1 
for 14 days) of Col supplementation are only able to partly 
blunt intestinal injury during exercise with combined heat 
stress. This finding is in agreement with our results from a 
series of previous investigations [1, 2, 11] showing that this 
supplementation regime cannot fully blunt the increase in 
intestinal damage during exercise. This also supports the 
notion that combinations of supplements to confer further 
benefit against intestinal damage in the exercise (and heat) 
stress model may be more efficacious [1].
Consistent with previous studies [5, 41], plasma I-FABP 
levels approximated pre-exercise levels in the current study 
60 min following the termination of exercise which likely 
underlines the ability of the intestines to withstand short peri-
ods of reduced perfusion (ischaemia) and to rapidly restore the 
intestinal barrier (restitution). Full restoration of the intestinal 
barrier through intestinal cell migration 60 min after a 30 min 
ischaemic period has previously been reported [42]. However, 
even these comparatively short periods of intestinal barrier 
injury (where permeability is increased) are likely still of clin-
ical relevance. For example, LPS translocation has previously 
been described following exercise of shorter duration than 
the present study [43]. It is possible that Col could enhance 
the migration of intestinal cells in this post-ischaemic period 
which has been previously shown in vitro [44].
Fig. 4  Association between post-exercise absolute plasma I-FABP 
and Bacteroides/total bacterial DNA. Visit 1 (P = 0.038, Rs = 0.603) 
and Visit 2 (P = 0.060, Rs = 0.557)
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In the present study, and previously we have shown that 
Col supplementation can blunt both the exercise-induced 
increase in intestinal permeability as measured by the uri-
nary L/R (5 h) [1, 2, 11] and cellular damage as indicated 
by plasma I-FABP [2]. However, it may be considered more 
pertinent to investigate the effect of Col supplementation 
on the consequence of this increase in permeability (i.e. 
bacterial translocation) as this is associated with endotox-
aemia and in some cases (although rare) severe outcomes. 
Although the aforementioned issues pertaining to the col-
lection and analysis of blood samples, in addition to the 
detection of LPS (some components of human plasma can 
interfere with the LAL assay resulting in false positives), 
suggest that the use of this marker to assess the impact of 
intestinal permeability changes is less than ideal [18, 19]. 
Therefore, in the present study we measured the ratio of 
Baceteroides to total bacterial DNA. Bacteroides account 
for around 25% of the anaerobes found in the gastrointestinal 
tract, and are the most prevalent bacteria in the gut [45]. In 
the present study, Bacteroides/total 16S rDNA appeared to 
be lower overall following 14 days of Col supplementation 
which may indicate a direct effect of Col on intestinal per-
meability and subsequent bacterial translocation but it must 
be noted that there was no arm × time interaction showing 
the overall response to exercise was not influenced by Col. 
There was large inter-participant variation in this measure, 
and whilst this method appears advantageous in comparison 
with LPS assays (e.g. LAL) due to specificity for a particu-
lar bacterial strain, it may require a larger sample size to 
detect the magnitude of effect observed in this study. Alter-
natively, it may be valuable to also measure other abundant 
gut bacterial species at the same time to further explore the 
effects of exercise and Col. This is the first study to assess 
the effect of Col supplementation in an exercise and heat 
stress model with measures of bacterial translocation using 
the nucleic acid testing (NAT) model for bacterial DNA. It 
provides further evidence that 14 days of Col supplemen-
tation can reduce the increase in exercise-induced intesti-
nal permeability, and preliminary evidence that this may 
reduce bacterial translocation, but the latter requires further 
research (i.e. with a larger sample size and/or adding other 
bacterial strains to the detection panel). This study and oth-
ers [2, 30–32] have observed a large inter-participant vari-
ability (Plasma I-FABP was highly variable in both arms) 
in plasma I-FABP; therefore, future investigations should 
endeavour to understand how plasma I-FABP is influenced 
by factors such as diurnal variation and how it changes in 
the post-prandial period.
A limitation of the present study is that we did not attain 
training history or current training status from participants, 
it has been speculated that regular training may be protective 
against exercise-induced changes in intestinal permeability 
through an up-regulation in HSP [22, 46]. However, this 
has yet to be reliably demonstrated [47], and furthermore 
in the current study there was little variation for V̇O2peak 
values (SD < 5 mL kg−1 min−1) indicating a similar level 
of aerobic fitness for participants in the study (whom were 
all regular exercisers). Finally, the protocol employed in 
this study required participants to exercise at the same rela-
tive intensity, therefore, imposing a similar physiological 
stress between participants despite small variances in fitness 
through training status.
Conclusion
This is the first study to demonstrate the efficacy of Col 
to reduce intestinal injury following exercise in the heat. 
This could hold particular relevance to athletes who are 
required to compete in hot and humid conditions and those 
individuals whose work (e.g. soldiers, firefighters) neces-
sitates exhaustive physical exertion in such environments. 
Future studies may wish to determine the effects of Col in 
clinically diseased populations where endotoxaemia and 
subsequent inflammation contribute to the pathophysiology 
of the condition.
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